Dabrafenib-trametinib is effective in paediatric high-grade glioma
- PMID: 37726419
- DOI: 10.1038/s41571-023-00820-8
Dabrafenib-trametinib is effective in paediatric high-grade glioma
Comment on
-
Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory BRAF V600-Mutant Pediatric High-Grade Glioma.J Clin Oncol. 2023 Nov 20;41(33):5174-5183. doi: 10.1200/JCO.23.00558. Epub 2023 Aug 29. J Clin Oncol. 2023. PMID: 37643378 Free PMC article. Clinical Trial.
References
Original article
-
- Hargrave, D. R. et al. Phase II trial of dabrafenib plus trametinib in relapsed/refractory BRAF V600-mutant pediatric high-grade glioma. J. Clin. Oncol. https://doi.org/10.1200/JCO.23.00558 (2023) - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
